Try our Advanced Search for more refined results

September 20, 2010

Teva Pharmaceuticals USA, Inc. et al v. MYLAN Pharmaceuticals Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 11, 2013

    Mylan Says Teva's MS Drug IP Suit Doomed By Safe Harbor

    Mylan Inc. on Friday asked a New York federal judge to toss a patent infringement suit over Teva Pharmaceutical Industries Ltd.'s Copaxone, saying it was permitted under a federal safe harbor to use proprietary processes when developing a generic version of the multiple sclerosis drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!